Search results
Unveiling Moderna (MRNA) Q1 Outlook: Wall Street Estimates for Key Metrics
Zacks via Yahoo Finance· 5 days agoBeyond analysts' top -and-bottom-line estimates for Moderna (MRNA), evaluate projections for some of...
Moderna Inc (MRNA) (Q1 2024) Earnings Call Transcript Highlights
Guru Focus· 2 days agoFor the complete transcript of the earnings call, please refer to the full earnings call transcript. Moderna Inc (MRNA, Financial) reported substantial clinical progress with ...
Moderna Quarterly Sales Beat Expectations but Plummet From Previous Year
US News & World Report· 2 days agoSales of Moderna’s COVID-19 shot Spikevax, its only marketed product, dropped 91% from the previous year to $167 million for the quarter but surpassed analysts’ expectations ...
Thousands Believe Covid Vaccines Harmed Them. Is Anyone Listening?
New York Times· 21 hours agoWithin minutes of getting the Johnson & Johnson Covid-19 vaccine, Michelle Zimmerman felt pain...
Smart Money Is Betting Big In MRNA Options - Moderna (NASDAQ:MRNA)
Benzinga· 4 days agoLoading... Loading... Whales with a lot of money to spend have taken a noticeably bullish stance on Moderna . Looking at options history for Moderna MRNA ...
Moderna Inc (MRNA)'s Uncertain Future: Understanding the Barrier
Guru Focus· 2 days agoLong-established in the Biotechnology industry, Moderna Inc (MRNA, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth ...
Why Moderna Partnered with OpenAI
Analytics India Magazine· 5 days ago“People literally talk about how AI is going to cure diseases someday, and I think this is a very meaningful first step,” said CEO Sam Altman about...
Why Earnings Season Could Be Great for Moderna (MRNA)
Zacks· 3 days agoFree Report) may be one such company. In fact, the Most Accurate Estimate for the current quarter is currently at a loss of $3.55 per share for MRNA, narrower than the broader Zacks Consensus ...
Shhh! 3 Secret Biotech Stocks Flying Below Wall Street's Radar
InvestorPlace· 2 days agoBiotech stocks are full of intriguing innovators who could help pave the way for greater gains over...
Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates
Digital Journal· 2 days agoReports first quarter revenues of $167 million, GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)Prepares for launches of RSV vaccine and Spikevax® 2024-2025 formula; reaffirms 2024 ...